Botanical species · safety record

Ipomoea purpurea

The EFSA Compendium of Botanicals holds 4 constituent measurements and 1 genotoxicity assay for Ipomoea purpurea. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Ipomoea purpurea (L.) Roth.

4Constituent measurements

1Safety records

4Cited sources

5Licensed products (Canada)

Also recorded as

Pharbitis purpurea Asch. in Schweinf.

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 5 licensed products naming Ipomoea purpurea as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

Source material stated

New material

What the records describe

Constituents measured

Plant parts

Preparations

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Ergoline alkaloids	Seed	Solvent extraction	≤ 0.813 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Ergoline alkaloids	Seed	Solvent extraction	≥ 0.423 Milligram/gram	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Lysergic acid	Unspecified	Solvent extraction	—	Standard Chromatographic tests (paper- thin layer- and column chromatography)	No resolvable identifier
Umbelliferone	Unspecified	—	—	High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)	No resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

Outcome	Endpoint	Test	Tested organism	Metabolic activation	Source
Positive	gene mutation	bacterial reverse mutation assay	Salmonella typhimurium (as organism)	With and without	No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Wang, Jin-Lan., Hua, Zhun., Zhao, Bao-Ying., Tang, Wan-Xia., Zhang, Shu-Jun. Studies on the chemical constituents of Pharbitis purpurea .. Zhong yao cai = zhongyaocai = journal of chinese medicinal materials, 2010, vol. 33, no. 10, p. 1571-4.
Friedman, Mendel., Henika, Philip R. Mutagenicity of toxic weed seeds in the Ames test: jimson weed (Datura stramonium), velvetleaf (Abutilon theophrasti), morning glory (Ipomoea spp.), and sicklepod (Cassia obtusifolia). Journal of agricultural and food chemistry, 1991, p. 494-501.
Genest, K. A direct densitometric method on thin-layer plates for the determination of lysergic acid amide, isolysergic acid amide, and clavine alkaloids in morning glory seeds. Journal of chromatography, 1965, p. 531-539.
Hylin, John W., Watson, Donald P. Ergoline alkaloids in tropical wood roses. Science (washington, dc, united states), 1965, p. 499-500.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature